• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

StemCells Inc

+ Add to Watchlist

STEM:US

1.5400 USD 0.00000.00%

As of 20:10:00 ET on 08/29/2014.

Snapshot for StemCells Inc (STEM)

Open: 1.5500 Day's Range: 1.5200 - 1.5600 Volume: 510,438
Previous Close: 1.5400 52wk Range: 1.1500 - 2.4300 1-Yr Rtn: -1.28%

Stock Chart for STEM

No chart data available.
  • STEM:US 1.5400
  • 1D
  • 1M
  • 1Y
1.5400
Interactive STEM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for STEM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6614
Est. EPS (USD) (12/2014) -0.7030
Est. PEG Ratio -
Market Cap (M USD) 105.70
Shares Outstanding (M) 68.64
30 Day Average Volume 852,965
Price/Book (mrq) -
Price/Sale (ttm) 63.9485
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for STEM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for STEM

StemCells, Inc. is a biotechnology company. The Company discovers, develops, and commercializes stem cell-based therapies to treat diseases of the central nervous system, liver, and the pancreas. StemCells seeks to repair or repopulate neural, or other tissue that has been damaged or lost as a result of disease or injury.

Martin M McGlynnPresident/CEOStephen HuhnVP:CNS Clinical Rsch/Chief Medical Ofcr
Gregory T SchiffmanExec VP:Finance/CFOAnn TsukamotoExec VP:Strategic Alliances
More Company Profile & Key Executives for STEM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil